Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 66

1.

Pharmaceutical care to patients treated with antidepressants.

Marques LA, Galduroz JC, Noto AR.

Rev Calid Asist. 2012 Jan-Feb;27(1):55-64. doi: 10.1016/j.cali.2011.07.002. Epub 2011 Oct 7. Review.

PMID:
21982751
[PubMed - indexed for MEDLINE]
2.

Effectiveness of pharmacist care in the improvement of adherence to antidepressants: a systematic review and meta-analysis.

Rubio-Valera M, Serrano-Blanco A, Magdalena-Belío J, Fernández A, García-Campayo J, Pujol MM, del Hoyo YL.

Ann Pharmacother. 2011 Jan;45(1):39-48. doi: 10.1345/aph.1P429. Epub 2011 Jan 4. Review.

PMID:
21205952
[PubMed - indexed for MEDLINE]
3.
4.

Cost effectiveness of a pharmacy-based coaching programme to improve adherence to antidepressants.

Bosmans JE, Brook OH, van Hout HP, de Bruijne MC, Nieuwenhuyse H, Bouter LM, Stalman WA, van Tulder MW.

Pharmacoeconomics. 2007;25(1):25-37.

PMID:
17192116
[PubMed - indexed for MEDLINE]
5.

The expert consensus guideline series. Pharmacotherapy of depressive disorders in older patients.

Alexopoulos GS, Katz IR, Reynolds CF 3rd, Carpenter D, Docherty JP; Expert Consensus Panel for Pharmacotherapy of Depressive Disorders in Older Patients.

Postgrad Med. 2001 Oct;Spec No Pharmacotherapy:1-86.

PMID:
17205639
[PubMed - indexed for MEDLINE]
6.

Measuring quality of pharmacotherapy for depression in a national health care system.

Busch SH, Leslie D, Rosenheck R.

Med Care. 2004 Jun;42(6):532-42.

PMID:
15167321
[PubMed - indexed for MEDLINE]
7.

[Changes in pharmacotherapy for depression].

Watanabe K.

Seishin Shinkeigaku Zasshi. 2010;112(11):1105-14. Review. Japanese.

PMID:
21226249
[PubMed - indexed for MEDLINE]
8.

Pharmacotherapy of early-onset depression. Update and new directions.

Martin A, Kaufman J, Charney D.

Child Adolesc Psychiatr Clin N Am. 2000 Jan;9(1):135-57. Review.

PMID:
10674194
[PubMed - indexed for MEDLINE]
9.

A pharmacy-based coaching program to improve adherence to antidepressant treatment among primary care patients.

Brook OH, van Hout H, Stalman W, Nieuwenhuyse H, Bakker B, Heerdink E, de Haan M.

Psychiatr Serv. 2005 Apr;56(4):487-9.

PMID:
15812103
[PubMed - indexed for MEDLINE]
10.

Tolerability and adherence issues in antidepressant therapy.

Masand PS.

Clin Ther. 2003 Aug;25(8):2289-304. Review.

PMID:
14512135
[PubMed - indexed for MEDLINE]
11.

Measuring antidepressant prescribing practice in a health care system using administrative data: implications for quality measurement and improvement.

Kerr EA, McGlynn EA, Van Vorst KA, Wickstrom SL.

Jt Comm J Qual Improv. 2000 Apr;26(4):203-16.

PMID:
10749005
[PubMed - indexed for MEDLINE]
12.

Factors associated with antidepressant adherence for Medicaid-enrolled children and adolescents.

Fontanella CA, Bridge JA, Marcus SC, Campo JV.

Ann Pharmacother. 2011 Jul;45(7-8):898-909. doi: 10.1345/aph.1Q020. Epub 2011 Jul 20.

PMID:
21775691
[PubMed - indexed for MEDLINE]
13.

The relationship of guideline-concordant depression treatment and patient adherence to oral diabetes medications.

Nau DP, Chao J, Aikens JE.

Res Social Adm Pharm. 2005 Sep;1(3):378-88.

PMID:
17138485
[PubMed - indexed for MEDLINE]
14.

[Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].

Llorca PM, Miadi-Fargier H, Lançon C, Jasso Mosqueda G, Casadebaig F, Philippe A, Guillon P, Mehnert A, Omnès LF, Chicoye A, Durand-Zaleski I.

Encephale. 2005 Mar-Apr;31(2):235-46. Review. French.

PMID:
15959450
[PubMed - indexed for MEDLINE]
15.

Effects of pharmacist monitoring on patient satisfaction with antidepressant medication therapy.

Bultman DC, Svarstad BL.

J Am Pharm Assoc (Wash). 2002 Jan-Feb;42(1):36-43.

PMID:
11833513
[PubMed - indexed for MEDLINE]
16.

Therapeutic options for treatment-resistant depression.

Shelton RC, Osuntokun O, Heinloth AN, Corya SA.

CNS Drugs. 2010 Feb;24(2):131-61. doi: 10.2165/11530280-000000000-00000. Review.

PMID:
20088620
[PubMed - indexed for MEDLINE]
17.

[Therapy resistance to antidepressants. Definition, prevalence, predictors, and interventional possibilities].

Möller HJ.

Nervenarzt. 2004 May;75(5):499-515; quiz 516-7. Review. German.

PMID:
15127144
[PubMed - indexed for MEDLINE]
18.

Antidepressant treatment for depression: total charges and therapy duration*

Dobrez DG, Melfi CA, Croghan TW, Kniesner TJ, Obenchain RL.

J Ment Health Policy Econ. 2000 Dec 1;3(4):187-197.

PMID:
11967455
[PubMed - as supplied by publisher]
19.

[Pharmacotherapy of depression: recent developments].

Baumann P.

Rev Med Suisse. 2007 Sep 19;3(125):2079-80, 2083-4. Review. French.

PMID:
17939526
[PubMed - indexed for MEDLINE]
20.

[Are there substantial reasons for contraindicating antidepressants in bipolar disorder? Part II: facts or artefacts?].

Hausmann A, Hörtnagl C, Walpoth M, Fuchs M, Conca A.

Neuropsychiatr. 2007;21(2):131-58. Review. German.

PMID:
17640499
[PubMed - indexed for MEDLINE]
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk